Turtle Cameron, CEO of Spyre Therapeutics ($SYRE), sold shares on the open market 11 times over the past year, totaling about $3.07 million. The most recent sale occurred on March 2, 2026. These sales rank 2,674th among 11,678 insiders in our database, below the average of $8.6 million per seller and 6.4 transactions. Turtle Cameron made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Damora Therapeutics, Inc. | $DMRA | Turtle Cameron | Not found | A | Stock Option (right to buy) | 37313 | $0.00 | 37,313.0000 | 1,327,212 | 9999.99% | 2.81% |
| March 2, 2026 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | S | Common Stock | 5900 | $41.73 | 651,640.0000 | 78,540,164 | 0.90% | 0.01% |
| March 2, 2026 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | S | Common Stock | 9100 | $42.49 | 642,540.0000 | 78,540,164 | 1.40% | 0.01% |
| Feb. 2, 2026 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | S | Common Stock | 14043 | $32.87 | 657,540.0000 | 77,592,130 | 2.09% | 0.02% |
| Feb. 2, 2026 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | S | Common Stock | 957 | $31.82 | 671,583.0000 | 77,592,130 | 0.14% | 0.00% |
| Jan. 9, 2026 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | A | Stock Option (Right to Buy) | 528000 | $0.00 | 528,000.0000 | 77,592,130 | 9999.99% | 0.68% |
| Jan. 2, 2026 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | S | Common Stock | 2191 | $31.79 | 672,007.0000 | 77,592,130 | 0.32% | 0.00% |
| Jan. 2, 2026 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | S | Common Stock | 100 | $32.39 | 671,907.0000 | 77,592,130 | 0.01% | 0.00% |
| Jan. 2, 2026 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | S | Common Stock | 12709 | $30.47 | 674,198.0000 | 77,592,130 | 1.85% | 0.02% |
| Dec. 1, 2025 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | S | Common Stock | 4005 | $29.83 | 686,907.0000 | 77,592,130 | 0.58% | 0.01% |
| Dec. 1, 2025 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | S | Common Stock | 10995 | $28.73 | 690,912.0000 | 77,592,130 | 1.57% | 0.01% |
| Nov. 3, 2025 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | S | Common Stock | 16845 | $23.66 | 701,907.0000 | 77,592,130 | 2.34% | 0.02% |
| Nov. 3, 2025 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | S | Common Stock | 28155 | $23.13 | 718,752.0000 | 77,592,130 | 3.77% | 0.04% |
| June 2, 2025 | Oruka Therapeutics, Inc. | $ORKA | Turtle Cameron | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 41,679,560 | 9999.99% | 0.04% |
| Jan. 15, 2025 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | A | Stock Option (Right to Buy) | 370000 | $0.00 | 370,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2024 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | A | Common Stock | 400 | $9.82 | 746,907.0000 | 0 | 0.05% | 0.00% |
| Feb. 1, 2024 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | A | Stock Option (Right to Buy) | 277750 | $0.00 | 277,750.0000 | 0 | 9999.99% | 0.00% |
| Nov. 24, 2023 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | C | Common Stock | 723440 | $0.00 | 746,507.0000 | 0 | 3136.26% | 0.00% |
| Nov. 22, 2023 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | A | Stock Option (Right to Buy) | 374000 | $0.00 | 374,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 24, 2023 | Spyre Therapeutics, Inc. | $SYRE | Turtle Cameron | Chief Executive Officer | C | Series A Preferred Stock | 18086 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |